Serum Levels of Tumor Necrosis Factor-α and Vascular Endothelial Growth Factor in the Subtypes of Clinical High Risk Individuals: A Prospective Cohort Study [Response to Letter]

JiaYi YeShanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai Engineering Research Center of Intelligent Psychological Evaluation and Intervention, Shanghai Key Laboratory of Psychotic Disorders, Shanghai, 200030, People’s Republic of China

TianHong ZhangShanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai Engineering Research Center of Intelligent Psychological Evaluation and Intervention, Shanghai Key Laboratory of Psychotic Disorders, Shanghai, 200030, People’s Republic of ChinaCorrespondence[email protected]

https://orcid.org/0000-0002-5379-7119

References

Lin C, Chen K, Yu J, et al. Relationship between TNF-alpha levels and psychiatric symptoms in first-episode drug-naive patients with schizophrenia before and after risperidone treatment and in chronic patients. BMC Psychiatry. 2021;21(1):561. doi:10.1186/s12888-021-03569-5
PubMed Web of Science ®Google Scholar
Zhang T, Zeng J, Ye J, et al. Serum complement proteins rather than inflammatory factors is effective in predicting psychosis in individuals at clinical high risk. Transl Psychiatry. 2023;13(1):9. doi:10.1038/s41398-022-02305-1
PubMed Web of Science ®Google Scholar
Zhang T, Tang X, Zhang Y, et al. Multivariate joint models for the dynamic prediction of psychosis in individuals with clinical high risk. Asian J Psychiatr. 2023;81:103468. doi:10.1016/j.ajp.2023.103468
PubMed Web of Science ®Google Scholar
Zhang T, Zeng J, Wei Y, et al. Changes in inflammatory balance correlates with conversion to psychosis among individuals at clinical high-risk: a prospective cohort study. Psychiatry Res. 2022;318:114938. doi:10.1016/j.psychres.2022.114938
PubMed Web of Science ®Google Scholar
Zhang T, Wang J, Xu L, et al. Further evidence that antipsychotic medication does not prevent long-term psychosis in higher-risk individuals. Eur Arch Psychiatry Clin Neurosci. 2022;272(4):591–602. doi:10.1007/s00406-021-01331-2
PubMed Web of Science ®Google Scholar

Serum Levels of Tumor Necrosis Factor-α and Vascular Endothelial Growth Factor in the Subtypes of Clinical High Risk Individuals: A Prospective Cohort Study [Response to Letter]

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Serum Levels of Tumor Necrosis Factor-α and Vascular Endothelial Growth Factor in the Subtypes of Clinical High Risk Individuals: A Prospective Cohort Study [Response to Letter]

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date